18 Aug EFFECTIVE COMMUNICATION: THE KEY TO SUCCESS IN MYOPIA MANAGEMENT – PART 2

Posted at 09:34h in Blog, Thought Leadership by James Loughman

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1550676121841{}" z_index=""][vc_column width="2/3"][vc_single_image image="90795" img_size="723x350" qode_css_animation=""][vc_separator type="transparent"][vc_column_text]As outlined in Part 1, effective communication is particularly important for comprehensive myopia management. A key issue to address is how to successfully convince patients of the need and benefits of...

Read More

07 Apr EFFECTIVE COMMUNICATION: THE KEY TO SUCCESS IN MYOPIA MANAGEMENT – PART 1

Posted at 13:47h in Blog, Thought Leadership by James Loughman

The emergence of new therapies to limit myopia progression offers eyecare practitioners (ECPs) the opportunity to deliver better health outcomes for their patients. Despite growing calls for myopia control to become the new standard of care,(1)uptake of these new treatments by practitioners is still limited....

Read More

28 Oct Macular Health in Glaucoma: Is Macular Pigment Important?

Posted at 09:00h in Blog, Thought Leadership by James Loughman

Lutein, zeaxanthin and meso-zeaxanthin preferentially accumulate in neural tissue, including the macula, where they form macular pigment. Macular pigment has been extensively researched in terms of ocular health and disease prevention, particularly in relation to age-related macular degeneration (AMD). A less obvious target for macular...

Read More

16 Aug MANAGING MYOPIA: EVOLUTION OF A NEW STANDARD OF CARE

Posted at 12:41h in Blog, Thought Leadership by James Loughman

Scientific and industrial innovators have responded to the threat posed by myopia. We now have a rapidly increasing range of treatments available which have been shown to delay myopia onset, reduce or eliminate the progression of myopia in some children and thereby reduce the risk...

Read More

26 Apr The global impact of Covid-19 on eyecare and eye health – Part 2

Posted at 18:35h in Blog, Thought Leadership by James Loughman

According to a recent meta-analysis of published studies, approximately 11% of COVID-19 patients have exhibited direct ocular effects (1). Typically, the complications appear to be relatively mild and short-term. ...

Read More

08 Feb The global impact of Covid-19 on eyecare and eye health – Part 1

Posted at 19:00h in News by James Loughman

The emergence of the COVID-19 pandemic has had an immediate and dramatic impact on eyecare. Even now, more than a year since the emergence of this public health crisis, Covid-19 continues to overwhelm healthcare systems and resources around the globe. ...

Read More

21 Aug PUBLIC HEALTH APPROACHES TO MYOPIA PREVENTION AND CONTROL – PART 2

Posted at 15:21h in Blog, Thought Leadership by James Loughman

We will now examine how a successful public health strategy for myopia might be implemented, and what policy measures might generate sufficient impact to reverse the myopia epidemic....

Read More

05 Aug PUBLIC HEALTH APPROACHES TO MYOPIA PREVENTION AND CONTROL

Posted at 15:52h in News by James Loughman

The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia....

Read More

05 Aug Public Health approaches to Myopia prevention and control – Part 1

Posted at 13:22h in Blog, Thought Leadership by James Loughman

The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia....

Read More